Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Nicotinamide Mononucleotide

VitaminNMNBest in the morningBest taken with food

Useful mainly for people wanting to raise NAD+ levels, with clinical benefits still unproven.

Quick decision guide

May help most

people wanting to raise NAD+ levels, with clinical benefits still unproven

Common dosing range

250–500 mg/day

When to expect effects

Weeks (for NAD+ levels)

Watch out for

long-term safety beyond ~12 weeks is uncharacterized; US regulatory status is uncertain

What is it

Nicotinamide mononucleotide (NMN) is a direct precursor to nicotinamide adenine dinucleotide (NAD+), an essential coenzyme involved in energy metabolism, DNA repair, and cellular signaling. NMN is marketed primarily as a longevity supplement intended to raise declining NAD+ levels with age.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You specifically want to raise NAD+ and accept uncertain clinical payoff
You will keep the dose in the studied 250–500 mg range
You can tolerate regulatory and long-term-safety uncertainty

Probably skip if

You expect proven longevity, cognitive, or anti-aging benefits
You have active cancer or take PARP inhibitors (without oncology advice)
You are pregnant or breastfeeding

Evidence at a glance

raising nad+ levels

Good Evidence
Effect
Consistent rise in NAD+
Best fit
adults seeking to raise declining NAD+
Time
Weeks

physical function in older adults

Limited Evidence
Effect
Small
Best fit
older adults with reduced physical function
Time
Weeks to months

aerobic capacity / exercise performance

Limited Evidence
Effect
Small
Best fit
trained or amateur athletes
Time
Weeks

insulin sensitivity

Limited Evidence
Effect
Modest in specific groups
Best fit
postmenopausal women with prediabetes/overweight (where a trial saw effects)
Time
Weeks

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

raising nad+ levels

Biomarker support
Good Evidence

Oral NMN is converted to NAD+ and several small human studies show it raises blood NAD+ levels over weeks. This is a biomarker change; whether higher NAD+ from supplementation produces meaningful clinical benefits in humans is still being investigated.

Effect size
Consistent rise in NAD+
Time to effect
Weeks
Best fit
adults seeking to raise declining NAD+

Bottom line: NMN reliably raises NAD+, but a higher NAD+ level is not itself a proven health outcome.

physical function in older adults

Supplement benefit
Limited Evidence

A few small trials report modest improvements in measures such as walking or grip in older adults taking NMN. Studies are small and short, so the findings are preliminary.

Effect size
Small
Time to effect
Weeks to months
Best fit
older adults with reduced physical function

Bottom line: Possible small gains in physical function in older adults, on limited evidence.

aerobic capacity / exercise performance

Supplement benefit
Limited Evidence

Small studies, including in amateur runners, report modest improvements in aerobic capacity with NMN at higher doses. Replication is limited and effect sizes are small.

Effect size
Small
Time to effect
Weeks
Best fit
trained or amateur athletes

Bottom line: Preliminary signal for aerobic capacity that needs larger confirmation.

insulin sensitivity

Biomarker support
Limited Evidence

One trial in postmenopausal women with prediabetes reported improved muscle insulin sensitivity with NMN, but other studies have not shown broad metabolic benefits. The endpoint is a metabolic biomarker, not a diabetes outcome.

Effect size
Modest in specific groups
Time to effect
Weeks
Best fit
postmenopausal women with prediabetes/overweight (where a trial saw effects)

Bottom line: A biomarker signal for insulin sensitivity in select groups, not a general metabolic fix.

Evidence is mixed

One positive trial in a specific population contrasts with other studies that found no clear metabolic benefit.

How it works

NMN is converted to NAD+ via the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase). NAD+ is required for hundreds of cellular reactions, including those catalyzed by sirtuins (SIRT1-7), PARPs (involved in DNA repair), and CD38 (an immune signaling enzyme). Cellular NAD+ levels decline with age, and this decline is implicated in mitochondrial dysfunction, reduced DNA repair, and metabolic decline associated with aging. Oral NMN appears to be absorbed in the small intestine and converted to NAD+ in tissues. The exact mechanism of absorption was debated until the identification of the Slc12a8 transporter for NMN in mice, though its role in humans is still being investigated. Some evidence suggests NMN may be partially broken down to nicotinamide riboside (NR) in the gut before absorption, then reconverted to NMN intracellularly. NMN raises NAD+ levels in animal studies and several small human studies. Whether higher NAD+ levels achieved through supplementation produce meaningful clinical benefits in humans is still being investigated.

How to take it

1. Typical dose
250–500 mg/day
2. Higher studied dose
up to 1,200 mg/day (no clear added benefit)
3. Timing
morning, empty stomach or with breakfast
4. With food
either; with food is fine
5. How long to try
Most human data run 12 weeks or less; reassess

What to track

tolerability (nausea, flushing)
subjective energy or exercise capacity
NAD+ blood level if testing is available

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Standard NMN powder/capsule

Available in capsules and powder. Quality control varies widely; third-party testing is recommended.

Most common form; absorbed orally in the small intestine.

Sublingual NMN

May offer faster onset and modest bioavailability advantages.

Absorbed through oral mucosa, potentially bypassing some first-pass metabolism.

Liposomal NMN

Higher cost; bioavailability claims often outpace clinical evidence.

Phospholipid encapsulation for improved stability and absorption.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

nauseaindigestionheadacheflushing

Who should avoid it

  • pregnancy and breastfeeding
  • active cancer (consult oncologist)
  • PARP-inhibitor chemotherapy without supervision

Pregnancy & breastfeeding

Avoid during pregnancy and breastfeeding due to absence of safety data.

Interactions

PARP inhibitors / NAD-targeting chemotherapyModerate

theoretical interference via NAD+ and sirtuin pathways

Protocols featuring Nicotinamide Mononucleotide

Evidence-backed routines where Nicotinamide Mononucleotide plays a role.

Food sources

Broccoli

Amount
1 cup
%DV

Cabbage

Amount
1 cup
%DV

Cucumber

Amount
1 cup
%DV

Edamame

Amount
1/2 cup
%DV

Avocado

Amount
1/2 medium
%DV

Tomato

Amount
1 medium
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

stated NMN purity and dose
third-party purity/identity testing
reputable raw-material source (e.g. Uthever)

Be skeptical of

"reverses aging"
"extends lifespan"
"restores youth"

Frequently asked questions

Does NMN actually slow aging?

NMN raises NAD+ levels and shows lifespan effects in rodents. Whether it slows aging or extends life in humans has not been demonstrated. Claims linking NMN to longevity in humans are speculative.

What's the difference between NMN and NR?

Both are NAD+ precursors. NMN is one step closer to NAD+ in the biosynthesis pathway, but NR appears to enter cells more readily in most tissues. Clinical effects between the two are largely similar in available studies.

Is NMN still legal to sell in the US?

As of late 2022, the FDA took the position that NMN was being investigated as a drug and excluded from the dietary supplement definition. Regulatory and legal status remains in flux; check current guidance before purchasing.

How long until I see benefits?

Blood NAD+ levels typically rise within a few weeks. Subjective effects, when they occur, are variable. Most clinical trials run 8 to 12 weeks.

Is NMN safe long-term?

Short-term human safety appears acceptable. Long-term human safety data are limited. Theoretical concerns about effects on cancer cell proliferation exist but are unresolved.

References by claim

raising nad+ levels

Katayoshi et al., 2023PMC (2023) link

Morifuji et al., 2024PMC (2024) link

physical function in older adults

Prokopidis et al., 2025PMC (2025) link

Yoshino et al., 2021PMC (2021) link

aerobic capacity / exercise performance

Liao et al., 2021PMC (2021) link

Track Nicotinamide Mononucleotide with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.